In the second of a tw0-part interview, LeafCann chief executive Elisabetta Faenza tells Cannabiz of the company’s future plans – including the development of a $350m facility – and reveals how it will make medicinal cannabis more affordable for patients.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

For those becoming restless over the progress of Australia’s medicinal cannabis industry, a relatively recent history lesson may be in order.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...